VC
VCT.LSE Victrex plc
- Market cap
- GBX 795M
- P/E
- -
- P/B
- 2.20x
- ROE
- -35.7%
- Dividend yield
- 6.52%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is VCT.LSE undervalued?
Graham numberThe Graham number of Victrex plc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Victrex plc fundamental analysis
No fundamental analysis for Victrex plc yet.
Victrex plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Victrex plc
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, aerospace, automotive, and electroni…
Full company profileVictrex plc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Victrex plc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 252M | 290M | 326M | 294M | 266M | 306M | 341M | 307M | 296M | 296M | 588M |
| Gross Profit | 159M | 184M | 208M | 182M | 141M | 157M | 175M | 163M | 134M | 133M | 240M |
| Operating Income | 101M | 113M | 127M | 112M | 76.6M | 93.4M | 88.5M | 73.2M | 45.8M | 39.8M | 76.0M |
| EBITDA | 116M | 129M | 145M | 122M | 85.0M | 116M | 121M | 96.0M | 69.7M | 61.1M | 126M |
| Net Income | 82.5M | 99.5M | 111M | 92.4M | 54.2M | 73.2M | 76.2M | 61.7M | 17.2M | 27.8M | -129M |
| EPS | 0.97 | 1.16 | 1.28 | 1.07 | 0.63 | 0.84 | 0.87 | 0.71 | 0.20 | 0.32 | -1.48 |
| Balance Sheet | |||||||||||
| Total Assets | 473M | 538M | 564M | 536M | 550M | 615M | 642M | 627M | 592M | 567M | 505M |
| Total Liabilities | 83.6M | 59.7M | 73.9M | 74.6M | 68.5M | 104M | 151M | 126M | 130M | 136M | 162M |
| Shareholders' Equity | 389M | 478M | 490M | 462M | 478M | 509M | 489M | 499M | 461M | 434M | 362M |
| Cash & Short-term Investments | 64.0M | 120M | 144M | 72.8M | 73.1M | 112M | 68.8M | 33.5M | 29.3M | 24.2M | 31.7M |
| Total Debt | - | - | - | - | 7.10M | 15.9M | 32.1M | 50.2M | 50.4M | 49.0M | 77.1M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 83.4M | 118M | 129M | 80.1M | 69.4M | 127M | 80.0M | 41.7M | 84.0M | 71.1M | 116M |
| Capital Expenditure | 25.9M | 16.7M | 9.90M | 22.7M | 24.9M | 41.9M | 45.5M | 38.5M | 32.6M | 21.8M | 29.6M |
| Free Cash Flow | 57.5M | 101M | 119M | 57.4M | 44.5M | 85.2M | 34.5M | 3.20M | 51.4M | 49.3M | 86.4M |
| Ratios | |||||||||||
| ROE | 21.2% | 20.8% | 22.6% | 20.0% | 11.3% | 14.4% | 15.6% | 12.4% | 3.7% | 6.4% | -35.7% |
| ROA | 17.5% | 18.5% | 19.6% | 17.2% | 9.9% | 11.9% | 11.9% | 9.8% | 2.9% | 4.9% | -25.6% |
| Net Profit Margin | 32.7% | 34.3% | 33.9% | 31.4% | 20.4% | 23.9% | 22.3% | 20.1% | 5.8% | 9.4% | -22.0% |
| Debt to Equity | - | - | - | - | 0.01x | 0.03x | 0.07x | 0.10x | 0.11x | 0.11x | 0.21x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Victrex plc dividends
- Dividend yield
- 6.52%
- Forward dividend
- 0.60 GBX
- Payout ratio
- 186.3%
- Ex-dividend date
- May 28, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | GBP 51.8M | 0.59 | 186.3% |
| 2024 | GBP 51.8M | 0.59 | 301.2% |
| 2023 | GBP 51.8M | 0.59 | 84.0% |
| 2022 | GBP 95.2M | 1.09 | 124.9% |
| 2021 | GBP 51.6M | 0.59 | 70.5% |
| 2020 | GBP 39.9M | 0.46 | 73.6% |
| 2019 | GBP 122M | 1.42 | 132.5% |
| 2018 | GBP 106M | 1.22 | 95.5% |
| 2017 | GBP 40.4M | 0.47 | 40.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Victrex plc
- Insiders 0.88%
- Institutions 86.52%
- Public & others 12.61%
- Shares outstanding 87.2M
- Free float 70.3M
Victrex plc company profile
- Company name
- Victrex plc
- Ticker
- VCT.LSE
- ISIN
- GB0009292243
- Exchange
- London Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,169
- Fiscal year end
- September
- Address
- Victrex Technology Centre, Thornton-Cleveleys, United Kingdom, FY5 4QD
- Phone
- 44 12 5389 7700
- Website
- victrexplc.com
About Victrex plc
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, aerospace, automotive, and electronics markets, as well as engages in trading activities. It serves automotive, aerospace, energy and industrial, electronics, and medical markets. Victrex plc was incorporated in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.
Victrex plc management
7- Dr. James Mathew Routh Ph.D.CEO & Executive Director · born 1973
- Mr. Chris GilbertInterim Chief Financial Officer
- Mr. Suranjan GhoshChief Operations & Transformation Officer
- Ms. Jilly AthertonGroup Human Resource Director
- Dr. John Devine Bsc Ph.D.Managing Director for Medical
- Daniel DiffenderferManaging Director of Medical
- Mr. Andrew NgChief Commercial Officer